Published on 24 Jan 2023 on Reuters
Eli Lilly to invest $450 million more to expand diabetes drug plant capacity
The company has been struggling to meet high demand for the drugs Trulicity and Mounjaro, especially...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free